IPMK expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.373200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.892800E-01
Normal-vs-Stage2
8.819000E-01
Normal-vs-Stage3
3.991000E-01
Normal-vs-Stage4
4.585400E-01
Stage1-vs-Stage2
6.776600E-01
Stage1-vs-Stage3
2.216200E-01
Stage1-vs-Stage4
3.914200E-01
Stage2-vs-Stage3
3.890800E-01
Stage2-vs-Stage4
1.865980E-01
Stage3-vs-Stage4
9.183700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.738200E-01
Normal-vs-AfricanAmerican
3.861800E-01
Normal-vs-Asian
6.308200E-01
Caucasian-vs-AfricanAmerican
1.756170E-02
Caucasian-vs-Asian
5.797200E-01
AfricanAmerican-vs-Asian
6.764100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.633200E-01
Normal-vs-Female
9.294400E-01
Male-vs-Female
4.645600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.693200E-01
Normal-vs-Age(41-60Yrs)
7.582400E-01
Normal-vs-Age(61-80Yrs)
6.293600E-01
Normal-vs-Age(81-100Yrs)
3.325400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.617600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.129200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.899200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.217990E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.568300E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.924800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.147400E-01
Normal-vs-Daily Drinker
4.559200E-01
Normal-vs-Weekly Drinker
6.710600E-01
Normal-vs-Occasional Drinker
7.986800E-01
Normal-vs-Social Drinker
9.405000E-01
Non Drinker-vs-Daily Drinker
8.336000E-01
Non Drinker-vs-Weekly Drinker
6.845400E-01
Non Drinker-vs-Occasional Drinker
7.664100E-02
Non Drinker-vs-Social Drinker
2.978200E-01
Daily Drinker-vs-Weekly Drinker
5.692800E-01
Daily Drinker-vs-Occasional Drinker
7.087800E-02
Daily Drinker-vs-Social Drinker
2.529200E-01
Weekly Drinker-vs-Occasional Drinker
2.581800E-01
Weekly Drinker-vs-Social Drinker
4.850200E-01
Occasional Drinker-vs-Social Drinker
7.884600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
N/A
Normal-vs-Grade 2
N/A
Normal-vs-Grade 3
N/A
Normal-vs-Grade 4
N/A
Grade 1-vs-Grade 2
1.933840E-01
Grade 1-vs-Grade 3
1.081390E-01
Grade 1-vs-Grade 4
N/A
Grade 2-vs-Grade 3
6.544800E-01
Grade 2-vs-Grade 4
N/A
Grade 3-vs-Grade 4
N/A
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.205600E-01
Normal-vs-NonDiabetic
7.132800E-01
Diabetic-vs-NonDiabetic
8.734000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.441600E-01
Normal-vs-NoPancreatitis
7.560200E-01
Pancreatitis-vs-NoPancreatitis
7.818600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.665600E-01
Normal-vs-N1
8.826400E-01
N0-vs-N1
6.004600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.079200E-01
Normal-vs-TP53-NonMutant
9.213400E-01
TP53-Mutant-vs-TP53-NonMutant
9.897200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
